ClassID:

20298

A61K31/365 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones

Recent Application in this class:
#901
20160213700
2016-07-28

Treatment of chronic obstructive pulmonary disease (COPD)

#902
20160213698
2016-07-28

Compositions comprising rutin useful for the treatment of tumors resistant to chemotherapy

#903
20160213696
2016-07-28

Treatment of CYR61- and VEGF-mediated conditions

#904
20160202243
2016-07-14

MITOCHONDRIA AND HUMAN IMMUNODEFIENCY VIRUS TYPE 1 TRANSMISSION

#905
20160199345
2016-07-14

Use of wilforlide A for overcoming chemotherapy resistance

#906
20160199296
2016-07-14

NASAL FORMULATIONS OF BENZODIAZEPINE

#907
20160194400
2016-07-07

Antibody which specifically reacts with human integrin A6B4

#908
20160193296
2016-07-07

METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS

#909
20160193268
2016-07-07

ANDROGRAPHIS PANICULATA EXTRACT

#910
20160193180
2016-07-07

Composition for treating immune diseases containing daurinol compound as active ingredient

#911
20160193173
2016-07-07

Ketone bodies and ketone body esters as blood lipid lowering agents

#912
20160175436
2016-06-23

COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES

#913
20160175435
2016-06-23

Treatment of pemphigus

#914
20160175281
2016-06-23

Immunosuppressive compounds and therapeutics

#915
20160175253
2016-06-23

Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof

#916
20160143975
2016-05-26

METHOD FOR PRODUCING TRIPTOLIDE

#917
20160137662
2016-05-19

Compositions and methods for treating cancer

#918
20160136229
2016-05-19

MATERIALS FOR POSITIVE CATHEPSIN B MODULATION AND METHODS OF USE FOR TREATING MILD COGNITIVE IMPAIRMENT (MCI), EARLY DEMENTIA, A-SYNUCLEINOPATHY, TRAUMATIC BRAIN INJURY, CARDIOMYOPATHY, EYE DISEASE AND SKIN DAMAGE

#919
20160136161
2016-05-19

Use of flibanserin in the treatment of obesity

#920
20160129230
2016-05-12

METHOD OF TREATMENT OF PREMALIGNANT AND MALIGNANT SKIN LESIONS WITH CYTOTOXIC AGENTS

#921
20160128933
2016-05-12

Therapeutic Methods and Compositions

#922
20160113938
2016-04-28

Animal training using cognitive enhancement

#923
20160113899
2016-04-28

Method of treating cancer that overexpresses TopBP1

#924
20160106751
2016-04-21

Small molecular inhibitors of RAD51 recombinase and methods thereof

#925
20160106699
2016-04-21

Oral pharmaceutical composition containing combination of PPARa and a HMG-CoA reductase inhibitor

#926
20160089364
2016-03-31

Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception

#927
20160082059
2016-03-24

Method for preventing or treating neurodegenerative diseases

#928
20160081979
2016-03-24

METHOD FOR SEPARATING THERAPEUTIC AGENT FOR CHRONIC MYELOGENOUS LEUKEMIA FROM BARK OF LIRIODENDRON TULIPIFERA L.

#929
20160081978
2016-03-24

PHARMACEUTICAL COMPOSITION CONTAINING LIRIODENDRON TULIPIFERA L. EXTRACT FOR TREATING CHRONIC MYELOGENOUS LEUKEMIA

#930
20160081977
2016-03-24

Pharmaceutical preparations

#931
20160075677
2016-03-17

Synthesis of resorcylic acid lactones useful as therapeutic agents

#932
20160074435
2016-03-17

KILLING ANTIBIOTIC-RESISTANT BACTERIA WITH A FORMULATION THAT IS SAFE FOR ORAL ADMINISTRATION

#933
20160074360
2016-03-17

COMBINED DRUG ADMINISTRATION OF DALCETRAPIB AND ORLISTAT

#934
20160074359
2016-03-17

METHODS OF STIMULATING CELLULAR GROWTH, SYNAPTIC REMODELING AND CONSOLIDATION OF LONG-TERM MEMORY

#935
20160074352
2016-03-17

Neprilysin inhibitors

#936
20160074339
2016-03-17

Methods and compositions for preventing and treating electrophile-mediated toxicities

#937
20160069864
2016-03-10

Reagents and methods for cancer treatment and prevention

#938
20160067271
2016-03-10

Methods And Compositions For Preventing Or Treating Obesity

#939
20160067261
2016-03-10

SERCA INHIBITOR AND CALMODULIN ANTAGONIST COMBINATION

#940
20160067163
2016-03-10

A Composition for Lightening Skin and Hair

#941
20160060679
2016-03-03

Compounds, substrates and methods related to histone deacetylases

#942
20160058733
2016-03-03

CDC7 kinase inhibitors and uses thereof

#943
20160058732
2016-03-03

METHOD FOR IMPROVING THE OXYGEN-RELEASING ABILITY OF HEMOGLOBIN TO ORGANS AND PERIPHERAL TISSUES IN HUMAN BODIES AND A MEDICATION THEREOF

#944
20160053438
2016-02-25

Method of making a paper and paperboard and the paper and paperboard thereof

#945
20160051524
2016-02-25

Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles

#946
20160051509
2016-02-25

Methods for Alzheimer'S disease treatment and cognitive enhancement

#947
20160051508
2016-02-25

Use of a macrocyclic lactone for treating a complication from a papilloma virus infection

#948
20160046709
2016-02-18

METHODS OF TREATMENT USING AN INTERFERON GAMMA INHIBITOR

#949
20160046594
2016-02-18

Anticancer miliusane derivatives

#950
20160045566
2016-02-18

Angiopoietin-based interventions for treating cerebral malaria

#951
20160045532
2016-02-18

Methods for modulating chemotherapeutic cytotoxicity

#952
20160045514
2016-02-18

Compounds and methods for inducing chondrogenesis

#953
20160038520
2016-02-11

Tannin inhibitors of HIV

#954
20160038454
2016-02-11

INTRAVENOUS FORMULATIONS OF TRIPTOLIDE COMPOUNDS AS IMMUNOMODULATORS AND ANTICANCER AGENTS

#955
20160031803
2016-02-04

Oligo-benzamide compounds and their use in treating cancers

#956
20160030589
2016-02-04

Methods of producing cancer compounds

#957
20160030388
2016-02-04

Diterpenoid membranolide compounds having anti-leishmania activity and uses thereof

#958
20160022818
2016-01-28

PHARMACEUTICAL FORMULATION COMPRISING LIPASE INHIBITOR HAVING INCREASED DISSOLUTION RATE AND REDUCED SIDE EFFECTS, AND METHOD FOR PREPARING SAME

#959
20160022706
2016-01-28

Treatment of lymphangioleiomyomatosis

#960
20160022614
2016-01-28

Compositions and methods for treating cancer

#961
20160008319
2016-01-14

PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS

#962
20160000751
2016-01-07

Method for treating and/or delaying the degeneration of Purkinje cells

#963
20150374661
2015-12-31

Biologically active macrolides, compositions, and uses thereof

#964
20150368217
2015-12-24

Derivative of homoserine lactone, and preparation method and use thereof

#965
20150366895
2015-12-24

Cancer therapy using miRNAs

#966
20150366891
2015-12-24

Edible energy composition

#967
20150353573
2015-12-10

Gem-difluorinated C-glycoside compounds as anti-cancer agents

#968
20150352378
2015-12-10

Method for treating skin cancer using radiation therapy

#969
20150352213
2015-12-10

Method for treating pancreatic cancer

#970
20150352075
2015-12-10

Treatment of Alzheimer's and Cognitive Impairment With Andrographolides

#971
20150335562
2015-11-26

Method of treating or reducing the severity of dermatological conditions

#972
20150320893
2015-11-12

TREATMENT OF LATENT HIV INFECTION

#973
20150306233
2015-10-29

Stable pharmaceutical composition

#974
20150306067
2015-10-29

Small molecule antagonists of bacterial quorum-sensing receptors

#975
20150297753
2015-10-22

Compositions for delivery of oral comfort sensations

#976
20150297572
2015-10-22

Calcium flux agonists and methods thereof

#977
20150297559
2015-10-22

Methods and compositions for treatment of lipid storage disorders

#978
20150297555
2015-10-22

Combination therapeutics and methods for the treatment of neurodegenerative and other diseases

#979
20150291551
2015-10-15

Ingenol-3-acylates III and ingenol-3-carbamates

#980
20150290318
2015-10-15

Combination of local and systemic immunomodulative therapies for melanoma and liver cancer

#981
20150290225
2015-10-15

COMPOSITIONS AND METHODS OF USING SAME

#982
20150290165
2015-10-15

Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

#983
20150283119
2015-10-08

Transdermal parasiticidal formulations

#984
20150283078
2015-10-08

Liposomes for in-vivo delivery

#985
20150274843
2015-10-01

Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof

#986
20150272959
2015-10-01

SMALL MOLECULES AS ANTI-HIV AGENTS THAT DISRUPT VIF SELF-ASSOCIATION AND METHODS OF USE THEREOF

#987
20150265573
2015-09-24

Coumarin compounds as receptor modulators with therapeutic utility

#988
20150265572
2015-09-24

INJECTABLE CANCER COMPOSITIONS

#989
20150259349
2015-09-17

Means and method for treating solid tumors

#990
20150246054
2015-09-03

Cognitive function

#991
20150246000
2015-09-03

Drug delivery system and method for the treatment of neuro-degenerative disease

#992
20150238460
2015-08-27

Methods and Compositions For Treating Hepatocellular Carcinoma

#993
20150231193
2015-08-20

Extracts of cynara scolymus, coffea ssp. and olea europaea for the treatment of metabolic syndrome

#994
20150231139
2015-08-20

THERAPY FOR CONSTIPATION

#995
20150231111
2015-08-20

Methods of treating skin conditions using cyclolignan compounds

#996
20150216926
2015-08-06

METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS

#997
20150216887
2015-08-06

Compositions for oral administration to animals, production methods thereof and uses of same

#998
20150216842
2015-08-06

Methods of treating skin conditions using cyclolignan compounds

#999
20150209355
2015-07-30

Spirocyclic isoxazoline parasiticidal combinations

#1000
20150203566
2015-07-23

FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES

#1001
20150202588
2015-07-23

Devices and methods for facilitating and controlling use of a medication

#1002
20150202240
2015-07-23

Compositions and methods for enhancing virus efficacy

#1003
20150202180
2015-07-23

Pharmaceutical compositions of anisomelic acid and the use thereof

#1004
20150196576
2015-07-16

Anti-cancer agent

#1005
20150196508
2015-07-16

Prion protein ligands as therapeutic agents for neurodegenerative disorders

#1006
20150192594
2015-07-09

Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies

#1007
20150183785
2015-07-02

Antiparisitic dihydroazole compounds and compositions comprising same

#1008
20150182496
2015-07-02

MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

#1009
20150174202
2015-06-25

Methods and Compositions for Modulating Beta Cell Proliferation

#1010
20150166503
2015-06-18

Treprostinil derivative compounds and methods of using same

#1011
20150164932
2015-06-18

Compositions That Include Anthocyanidins and Methods of Use

#1012
20150164864
2015-06-18

Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

#1013
20150164858
2015-06-18

COMBINATION COMPRISING PARTHENOLIDE FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS

#1014
20150157678
2015-06-11

fruit extract

#1015
20150157623
2015-06-11

COMBINATION OF SYROSINGOPINE AND MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOSUPPRESSION

#1016
20150157622
2015-06-11

Combination therapy for the treatment of cancer and immunosuppression

#1017
20150150893
2015-06-04

ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION

#1018
20150148364
2015-05-28

Artemisinin with berberine compositions and methods of making

#1019
20150140090
2015-05-21

Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation

#1020
20150139978
2015-05-21

Monascuspurpurones, preparation and uses thereof

#1021
20150133442
2015-05-14

Methods and compositions for the inhibition of Pin1

#1022
20150119388
2015-04-30

NOVEL PRO- AND CODRUG DERIVATIVES FOR NANOPARTICLE DELIVERY OF SELECT ANTICANCER AGENTS FORMED USING RAPIDLY CLEAVABLE PHENOLIC ESTER BRIDGES

#1023
20150105459
2015-04-16

Lichesterinic acid and the derivatives of same as pigmentation inhibitors

#1024
20150105458
2015-04-16

Line leaf inula flower lactone A and methods for preparing and using the same for treating multiple sclerosis

#1025
20150105457
2015-04-16

Line leaf inula flower lactone A and methods for preparing and using the same for treating myocarditis

#1026
20150094363
2015-04-02

Transplantation therapies

#1027
20150093345
2015-04-02

Anti-aging agent containing arctigenin derivative

#1028
20150087610
2015-03-26

Method of Modifying Fertility

#1029
20150086654
2015-03-26

NUTRITIONAL ENERGY AND FOCUS SUPPLEMENT

#1030
20150080349
2015-03-19

Modulation of bacterial quorum sensing with synthetic ligands

#1031
20150079189
2015-03-19

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

#1032
20150072994
2015-03-12

Use of Flibanserin in the Treatment of Obesity

#1033
20150057344
2015-02-26

PELTATIN FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISORDERS

#1034
20150056300
2015-02-26

THERAPEUTIC NANOPARTICLES WITH HIGH MOLECULAR WEIGHT COPOLYMERS

#1035
20150056267
2015-02-26

Angiogenesis inhibitors

#1036
20150051403
2015-02-19

Use of 15-benzylidene-14-deoxy-11, 12-dehydroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus

#1037
20150051277
2015-02-19

Compounds from Anisomeles Heyneana

#1038
20150050338
2015-02-19

Method for treatment of diarrhea-predominant irritable bowel syndrome

#1039
20150045425
2015-02-12

PELTATIN AND METABOLIC DISORDERS

#1040
20150038565
2015-02-05

Long acting compositions

#1041
20150038440
2015-02-05

Dihydrofuran azetidine derivatives as antiparasitic agents

#1042
20150031725
2015-01-29

Compositions and methods for treating cancer

#1043
20150030583
2015-01-29

Methods of Treating Serosal Cancer

#1044
20150025135
2015-01-22

Methods and compositions for treating leukemia

#1045
20150025061
2015-01-22

GABAA RECEPTOR ANTAGONISTS AFFECTING GANGLION CELL FUNCTION AND VISUAL ACUITY

#1046
20150025046
2015-01-22

Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists

#1047
20150017099
2015-01-15

Diagnosis and treatment for respiratory tract diseases

#1048
20150011624
2015-01-08

Method for extracting treatment ingredients for gastrointestinal diseases from bark of liriodendron tulipifera

#1049
20150011623
2015-01-08

Pharmaceutical Composition Containing as Active Ingredient Extract From Bark of Liriodendron Tulipifera

#1050
20150005487
2015-01-01

Sorbent comprising on its surface a cationic or protonizable aliphatic residue for the purification of organic molecules

#1051
20150005246
2015-01-01

Method of treating overactive bladder, not due to cancer, by administering at least one jasmonate

#1052
20140364387
2014-12-11

Methods and systems for modulating hormones and related methods, agents and compositions

#1053
20140357555
2014-12-04

Monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones

#1054
20140356458
2014-12-04

Treatment of sickle cell disease

#1055
20140350096
2014-11-27

Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer

#1056
20140343134
2014-11-20

Ellagitannins rich extracts composition in sexual wellness

#1057
20140343117
2014-11-20

METHODS AND PRODUCTS TO DIAGNOSE AND TREAT HEATINESS

#1058
20140343004
2014-11-20

Compositions for oral administration to animals, processes for obtaining the same and the uses thereof

#1059
20140335152
2014-11-13

Methods and compositions for enhancing the uptake of therapeutic agents by target cells

#1060
20140323568
2014-10-30

Oligo-benzamide compounds and their use in treating cancers

#1061
20140323563
2014-10-30

Use of strigolactones and strigolactone analogs for treating proliferative conditions

#1062
20140323559
2014-10-30

Long-acting injectable moxidectin formulations and novel moxidectin crystal forms

#1063
20140323507
2014-10-30

Mycophenolic acid analogues as anti-tumor chemosensitizing agents

#1064
20140322369
2014-10-30

Ellagitannins rich extracts composition

#1065
20140315990
2014-10-23

PKC activators and combinations thereof

#1066
20140315794
2014-10-23

Antiparisitic dihydroazole compounds and compositions comprising same

#1067
20140314746
2014-10-23

METHODS FOR TREATING OR PREVENTING FIBROSIS IN SUBJECTS AFFLICTED WITH SCLERODERMA

#1068
20140309181
2014-10-16

Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small molecules

#1069
20140308379
2014-10-16

Use of flaxseed and flaxseed derivatives for treatment of neurological disorders and viral diseases

#1070
20140303105
2014-10-09

Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens

#1071
20140296210
2014-10-02

Pharmacological treatment of cognitive impairment

#1072
20140294932
2014-10-02

Temperature sensitive liposome including cationic lipid and use thereof

#1073
20140288027
2014-09-25

Derivative of butylphthalide and preparation method and use thereof

#1074
20140275232
2014-09-18

Small molecule antagonists of bacterial quorum-sensing receptors

#1075
20140271955
2014-09-18

Compounds and methods for inducing chondrogenesis

#1076
20140271949
2014-09-18

Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting

#1077
20140271573
2014-09-18

PHARMACO-CELLULAR THERAPEUTIC METHOD FOR THE TREATMENT OF MUSCULAR DYSTROPHIES

#1078
20140256803
2014-09-11

Tumor necrosis factor inhibitors

#1079
20140256665
2014-09-11

Aminoglycoside and azole compositions and methods

#1080
20140256619
2014-09-11

Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones

#1081
20140242190
2014-08-28

Use of deoxyelephantopin (DET) and analogues thereof for reducing side effects of an anti-cancer agent

#1082
20140235528
2014-08-21

INHIBITING GS-FDH TO MODULATE NO BIOACTIVITY

#1083
20140228428
2014-08-14

extracts for the treatment of dyslipidaemia

#1084
20140228375
2014-08-14

Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity

#1085
20140213533
2014-07-31

Methods to detect, treat and prevent acute cellular rejection in kidney allografts

#1086
20140194495
2014-07-10

Cytotoxin compounds and methods of isolation

#1087
20140194374
2014-07-10

Anthelmintic Formulations and Treatments

#1088
20140193346
2014-07-10

HEALTH SUPPLEMENT

#1089
20140187627
2014-07-03

USES OF C15-SUBSTITUTED ANDROGRAPHOLIDE DERIVATIVES IN THE PREPARATION OF ANTI-HEPATITIS B VIRUS MEDICAMENT

#1090
20140174682
2014-06-26

Composition and use of hydrogenated alkyl ketene dimers

#1091
20140170250
2014-06-19

Pharmaceutical compositions and method for inhibiting angiogenesis

#1092
20140170162
2014-06-19

PRESERVATION OF THE NEUROMUSCULAR JUNCTION (NMJ) AFTER TRAUMATIC NERVE INJURY

#1093
20140170143
2014-06-19

Use of an anti-CD200 antibody for prolonging the survival of allografts

#1094
20140170112
2014-06-19

COMPOSITIONS FOR AMELIORATING SYSTEMIC INFLAMMATION AND METHODS FOR MAKING AND USING THEM

#1095
20140147519
2014-05-29

Migraine Treatment

#1096
20140147492
2014-05-29

METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AGENTS BY TARGET CELLS

#1097
20140142170
2014-05-22

COMPOSITION AND METHOD FOR INFLUENCING ENERGY METABOLISM AND TREATING METABOLIC AND OTHER DISORDERS

#1098
20140116916
2014-05-01

Therapy for Constipation

#1099
20140105969
2014-04-17

Compositions and methods for treating cancer

#1100
20140094508
2014-04-03

Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase

#1101
20140094466
2014-04-03

SSH-2 (slingshot-2) inhibitors and methods for making and using them

#1102
20140094418
2014-04-03

PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION

#1103
20140088186
2014-03-27

Composition containing arylnaphthalene lignan derivative for preventing and/or treating dementia

#1104
20140088182
2014-03-27

INFLAMMATORY EYE DISEASE

#1105
20140080849
2014-03-20

Small molecular inhibitors of RAD51 recombinase and methods thereof

#1106
20140080780
2014-03-20

Identification of compounds that disperse TDP-43 inclusions

#1107
20140080779
2014-03-20

Macrocyclic lactones and use thereof

#1108
20140073690
2014-03-13

Covalent inhibition of bacterial quorum sensing

#1109
20140073570
2014-03-13

Pharmaceutical composition and methods for peptide treatment

#1110
20140072663
2014-03-13

Compositions and methods for treating multi-drug resistant malaria

#1111
20140072662
2014-03-13

Andrographis Paniculata Compositions and Methods for Treatment of Addictions

#1112
20140056964
2014-02-27

GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING

#1113
20140056922
2014-02-27

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

#1114
20140051678
2014-02-20

INHIBITORS OF THE ACTIVITY OF COMPLEX III OF THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN AND USE THEREOF FOR TREATING DISEASES

#1115
20140045841
2014-02-13

Method of using antimycin A to downregulate Wnt/b-catenin pathway to treat gefitinib resistant cancer

#1116
20140045765
2014-02-13

Method for inhibiting autophagy of motor neurons

#1117
20140037770
2014-02-06

Burdock fruit extract containing arctigenin and method for producing same

#1118
20140024707
2014-01-23

Small molecule antagonists of bacterial quorum-sensing receptors

#1119
20140005259
2014-01-02

Microbicidal and antiparasitic compositions

#1120
20140005127
2014-01-02

Methods of treating muscular wasting diseases using NF-KB activation inhibitors

#1121
20140004212
2014-01-02

ANDROGRAPHIS PANICULATA EXTRACT

#1122
20140004177
2014-01-02

COX-2 INHIBITORS AND RELATED COMPOUNDS, AND SYSTEMS AND METHODS FOR DELIVERY THEREOF

#1123
20140004112
2014-01-02

Therapeutic peptides

#1124
20130345164
2013-12-26

TREATMENTS FOR CELLULAR PROLIFERATIVE DISORDERS AND IDENTIFICATION THEREOF

#1125
20130331738
2013-12-12

COMPOSITIONS AND METHODS FOR POTENTIATING SONOTHROMBOLYSIS

#1126
20130331445
2013-12-12

Picropodophyllin Monohydrate or Polymorph A in Cancer Therapy

#1127
20130331444
2013-12-12

Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activators

#1128
20130331323
2013-12-12

GLP-1 potentiators from hedychium coronarium and their applications

#1129
20130330332
2013-12-12

TREATMENT OF PEMPHIGUS

#1130
20130324595
2013-12-05

C-GLUCOSIDIC ELLAGITANNIN COMPOUNDS FOR USE FOR ALTERING THE SUPRAMOLECULAR ARRANGEMENT OF ACTIN AND FOR THE TREATMENT OF OSTEOPOROSIS, CANCER, BACTERIAL INFECTION AND VIRAL INFECTION

#1131
20130324594
2013-12-05

Methods and compositions for preventing and treating auditory dysfunctions

#1132
20130317099
2013-11-28

Picropodophyllin polymorph C and its use in cancer therapy

#1133
20130316966
2013-11-28

Use of albiflorin and metabolites thereof

#1134
20130316005
2013-11-28

Combination and composition for treating obesity

#1135
20130310451
2013-11-21

Tricyclic lactones for treatment of cancer

#1136
20130303600
2013-11-14

Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients

#1137
20130303489
2013-11-14

Multikinase inhibitors for use in the treatment of cancer

#1138
20130303466
2013-11-14

Chemosensory Receptor Ligand-Based Therapies

#1139
20130296411
2013-11-07

Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections

#1140
20130295207
2013-11-07

Skin whitening agent

#1141
20130281522
2013-10-24

Methods for Alzheimer's disease treatment and cognitive enhancement

#1142
20130281490
2013-10-24

Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)

#1143
20130281478
2013-10-24

Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression

#1144
20130281381
2013-10-24

Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans

#1145
20130280227
2013-10-24

Functional food preparation and use thereof

#1146
20130273114
2013-10-17

PHARMACEUTICAL COMPOSITIONS OF IMMUNOSUPPRESSANTS

#1147
20130261068
2013-10-03

Compositions and method for improving endothelial function and cardiovascular health

#1148
20130252908
2013-09-26

Pharmaceutical composition, methods for treating and uses thereof

#1149
20130237596
2013-09-12

Uses of 15-benzylidene-14-deoxy-11,12-didehydroandrographolide derivatives in the preparation of antineoplastic drugs

#1150
20130237560
2013-09-12

NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS

#1151
20130237525
2013-09-12

Lactam derivatives useful as orexin receptor antagonists

#1152
20130231371
2013-09-05

SPOT-ON PESTICIDE COMPOSITION CONTAINING A PYRETHROID AND MACROCYCLIC LACTONE

#1153
20130225531
2013-08-29

METHOD AND COMPOSITION FOR TREATING ALZHEIMER'S DISEASE AND DEMENTIAS OF VASCULAR ORIGIN

#1154
20130210775
2013-08-15

AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES

#1155
20130203692
2013-08-08

Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

#1156
20130197069
2013-08-01

METHODS FOR TREATING STRESS INDUCED EMOTIONAL DISORDERS

#1157
20130197017
2013-08-01

COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-11G

#1158
20130190394
2013-07-25

Applications Of Arctigenin In Formulating Drugs For Preventing Or Treating Diseases Related To Red Blood Cell Reduction

#1159
20130189380
2013-07-25

Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels

#1160
20130189299
2013-07-25

Method for manufacturing composition for lowering blood lipid and elevating high-density lipoprotein

#1161
20130184473
2013-07-18

Method for manufacturing composition for lowering blood lipid and elevating high-density lipoprotein

#1162
20130178434
2013-07-11

Method of treating otitis externa using macrocyclic lactone compound

#1163
20130178433
2013-07-11

Method of treating hemorrhoids using macrocyclic lactone compound

#1164
20130172282
2013-07-04

Method of treating herpes virus infection using macrocyclic lactone compound

#1165
20130165495
2013-06-27

Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors

#1166
20130165453
2013-06-27

THERAPEUTIC EFFECTS OF BRYOSTATINS, BRYOLOGS, AND OTHER RELATED SUBSTANCES ON ISCHEMIA/STROKE-INDUCED MEMORY IMPAIRMENT AND BRAIN INJURY

#1167
20130165375
2013-06-27

Treatment of depressive disorders

#1168
20130156822
2013-06-20

Drug delivery system and method for the treatment of neuro-degenerative disease

#1169
20130150432
2013-06-13

Improving efficacy of cancer therapy

#1170
20130143956
2013-06-06

Long-acting injectable moxidectin formulations and novel moxidectin crystal forms

#1171
20130137650
2013-05-30

Methods of treatment using combination therapy

#1172
20130136809
2013-05-30

7-HYRDROXYFRULLANOLIDE ITS ANALOGS FOR PREVENTION CONTROL AND TREATMENT OF METABOLIC DISORDERS

#1173
20130129773
2013-05-23

Anti-cancer active substance from , method for preparing the same and use thereof

#1174
20130123352
2013-05-16

Xanthanodien for the treatment of cancer

#1175
20130122110
2013-05-16

Anti-human urothelial carcinoma of supercritical carbon dioxide extract of , and the preparation process and uses

#1176
20130109749
2013-05-02

Micheliolide derivatives, medicinal composition, producing method and usage thereof

#1177
20130109745
2013-05-02

ANTI-ANGIOGENIC COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS

#1178
20130109733
2013-05-02

Combination of Selected Analgesics and Cox-II Inhibitors

#1179
20130109639
2013-05-02

Neprilysin inhibitors

#1180
20130102625
2013-04-25

Artemisinin with berberine compositions and methods of making

#1181
20130096086
2013-04-18

Mitochondria and human immunodefiency virus type 1

#1182
20130095110
2013-04-18

Hyaluronic acid decomposition-promoting factor and inhibitor thereof

#1183
20130090367
2013-04-11

Compositions and methods for inhibiting human host factors required for influenza virus replication

#1184
20130079406
2013-03-28

THERAPEUTIC COMPOSITIONS

#1185
20130079391
2013-03-28

LIPASE INHIBITING COMPOSITION

#1186
20130079355
2013-03-28

Use of flibanserin in the treatment of obesity

#1187
20130072562
2013-03-21

Tumor necrosis factor inhibitors

#1188
20130072550
2013-03-21

PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS

#1189
20130065850
2013-03-14

Treatment of viral infections by modulation of host cell metabolic pathways

#1190
20130052231
2013-02-28

Treatment methods utilizing stem cell mobilizers and immunosuppressive agents

#1191
20130045172
2013-02-21

USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS

#1192
20130045162
2013-02-21

DELIVERY SYSTEM FOR SPECIFICALLY TARGETING CANCER CELLS AND METHOD OF USE THEREOF

#1193
20130040967
2013-02-14

4′-demethylepipodophyllotoxin derivative, preparation method and use thereof

#1194
20130035378
2013-02-07

Film delivery system for tetrahydrolipstatin

#1195
20130035301
2013-02-07

CDC7 kinase inhibitors and uses thereof

#1196
20130023586
2013-01-24

USE OF TRICYCLIC SESQUITERPENE LACTONES IN THE TREATMENT OF OBESITY AND RELATED DISEASES AND NON-THERAPEUTIC TREATABLE CONDITIONS

#1197
20130023493
2013-01-24

extract

#1198
20130023487
2013-01-24

Compounds and compositions for treating infection

#1199
20130012576
2013-01-10

Composition for Lowering Blood Lipid and Elevating High-density Lipoprotein and Method for Manufacturing the Same

#1200
20130005722
2013-01-03

Pharmaceutical Composition of Mycophenolate Mofetil and Process for Preparing Thereof